T cell receptor gene-modified allogeneic T cells with siRNA for endogenous T cell receptor induce efficient tumor regression without graft-versus-host disease.
Okada S, Muraoka D, Yasui K, Tawara I, Kawamura A, Okamoto S, Mineno J, Seo N, Shiku H, Eguchi S, Ikeda H.
Cancer Sci. 2023 Nov;114(11):4172-4183. doi: 10.1111/cas.15954. Epub 2023 Sep 7.
PMID:37675556
Generation of a Graft versus Anticancer Immune Response Through Skin Allograft with Tumor.
Fang Y, Zhou S, Zheng B, Gong W, Huang Y, Zhang Z, Zhou C, Wang H, Huang Z, Zhong L, Zhao Y.
J Biomed Nanotechnol. 2018 Mar 1;14(3):575-584. doi: 10.1166/jbn.2018.2560.